eb05
Generic: paridiprubart
eb05: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Edesa Biotech, Inc. (EDSA) | Phase 3 |
Get deeper analysis on eb05
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis